Tweet
B. Riley set a $2.00 price target on Aemetis (NASDAQ:AMTX) in a research report sent to investors on Monday. The firm currently has a hold rating on the specialty chemicals company's stock. B. Riley also issued estimates for Aemetis' Q3 2018 earnings at ($0.31) EPS, Q4 2018 earnings at ($0.31) EPS, FY2018 earnings at ($1.40) EPS, Q1 2019 earnings at ($0.30) EPS, Q2 2019 earnings at ($0.26) EPS, Q3 2019 earnings at ($0.27) EPS, Q4 2019 earnings at ($0.22) EPS and FY2019 earnings at ($1.04) EPS.
Separately, Zacks Investment Research raised Aemetis from a sell rating to a hold rating in a research note on Thursday, June 14th. Get Aemetis alerts:
NASDAQ AMTX opened at $1.20 on Monday. The company has a current ratio of 0.27, a quick ratio of 0.11 and a debt-to-equity ratio of -1.53. Aemetis has a 12-month low of $0.45 and a 12-month high of $3.12. Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, August 9th. The specialty chemicals company reported ($0.27) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.34) by $0.07. equities analysts forecast that Aemetis will post -1.61 earnings per share for the current year.
About Aemetis
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries